Publication
Assessment of EGFR and HER2 expression in penile cancer as potential therapeutic targets.
Jan Niklas Mink, Jonas Boehle, Markus Eckstein, August Fiegl, Oybek Khalmurzaev, Alexey Pryalukhin, Carol Geppert, Stefan Lohse, Kristof Bende, João Lobo, Rui Henrique, Hagen Loertzer, Joachim Steffens, Carmen Jerónimo, Heiko Wunderlich, Rainer M Bohle, Michael Stöckle, Vsevolod Matveev, Arndt Hartmann, Kerstin Junker
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Penile cancer (PC) is a rare but aggressive malignancy with limited systemic treatment options, particularly in advanced stages. Targeted therapies against receptor tyrosine kinases such as EGFR and HER2 have demonstrated clinical benefit in other cancer types, yet their role in PC remains poorly…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Penile Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available